Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 228,698 | 147,449 | 104,644 | 70,156 | 187,335 |
| Marketable Securities | N/A | N/A | N/A | 247,636 | 73,008 |
| Receivables | 66,845 | 39,109 | 233,662 | 34,216 | 33,823 |
| Inventories | 61,017 | 116,349 | 114,245 | N/A | N/A |
| TOTAL | $371,437 | $309,533 | $468,275 | $358,356 | $296,321 |
| Non-Current Assets | |||||
| PPE Net | 8,622 | 10,380 | 8,023 | 3,617 | 2,612 |
| Intangibles | 199,223 | 346,265 | 383,206 | 0 | 0 |
| Other Non-Current Assets | 64,857 | 105,023 | 137,036 | 2,274 | 1,283 |
| TOTAL | $272,702 | $461,668 | $528,265 | $5,891 | $3,895 |
| Total Assets | $644,139 | $771,201 | $996,540 | $364,247 | $300,216 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | N/A | 15,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 41,308 | 39,217 | 42,796 | 6,998 | 2,039 |
| Accrued Expenses | 130,624 | 129,071 | 150,917 | 52,441 | 30,261 |
| TOTAL | $187,146 | $208,118 | $265,693 | $141,106 | $114,268 |
| Non-Current Liabilities | |||||
| Long Term Debt | 96,378 | 75,805 | N/A | N/A | N/A |
| Deferred Revenues | 15,214 | 39,830 | 56,980 | 81,667 | 81,968 |
| Other Non-Current Liabilities | 87,652 | 59,401 | 29,573 | 22 | 27 |
| TOTAL | $209,375 | $168,326 | $94,919 | $100,567 | $117,828 |
| Total Liabilities | $396,521 | $376,444 | $360,612 | $241,673 | $232,096 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 153,502 | 129,858 | 117,122 | 48,346 | 38,830 |
| Common Shares | 1 | 1 | 1 | N/A | N/A |
| Retained earnings | -1,177,511 | -794,054 | -514,395 | -370,807 | -297,136 |
| Other shareholders' equity | 13 | 0 | -261 | -442 | -42 |
| TOTAL | $247,618 | $394,757 | $635,928 | $122,574 | $68,120 |
| Total Liabilities And Equity | $644,139 | $771,201 | $996,540 | $364,247 | $300,216 |